New drug cocktail aims to halt leukemia in older patients
NCT ID NCT01515527
First seen Feb 06, 2026 · Last updated May 05, 2026 · Updated 11 times
Summary
This study tests whether a combination of three chemotherapy drugs (cladribine, low-dose cytarabine, and decitabine) can help control acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) in patients aged 60 and older. Participants receive the drugs in cycles, and researchers track how long the disease stays under control. The goal is to improve outcomes without a cure, as ongoing management is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.